PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 276 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 3.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $19,169 | -2.1% | 670 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $19,577 | -19.4% | 670 | -6.9% | 0.00% | 0.0% |
Q4 2023 | $24,294 | +13.9% | 720 | +3.6% | 0.00% | 0.0% |
Q3 2023 | $21,323 | -58.6% | 695 | -50.0% | 0.00% | 0.0% |
Q2 2023 | $51,479 | +117.9% | 1,390 | +100.0% | 0.00% | 0.0% |
Q1 2023 | $23,630 | +90784.6% | 695 | -5.6% | 0.00% | 0.0% |
Q4 2022 | $26 | -99.9% | 736 | -20.7% | 0.00% | 0.0% |
Q3 2022 | $36,000 | 0.0% | 928 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $36,000 | -40.0% | 917 | -43.1% | 0.00% | 0.0% |
Q1 2022 | $60,000 | +42.9% | 1,612 | +131.9% | 0.00% | 0.0% |
Q4 2021 | $42,000 | +7.7% | 695 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $39,000 | +1850.0% | 695 | +2680.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | -77.8% | 25 | -83.4% | 0.00% | – |
Q4 2020 | $9,000 | -88.9% | 151 | -88.9% | 0.00% | -100.0% |
Q3 2020 | $81,000 | – | 1,358 | – | 0.01% | – |
Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $9,000 | +200.0% | 200 | +100.0% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 100 | -9.9% | 0.00% | – |
Q2 2016 | $4,000 | -50.0% | 111 | +11.0% | 0.00% | -100.0% |
Q4 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |